Takeshi Masuda

Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads

Takashi Nakada, Takeshi Masuda, Hiroyuki Naito et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 169 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +14

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis

Kosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa et al. · Disease Markers · 2016 · 149 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +15

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi et al. · Respiratory Investigation · 2019 · 119 citations

Medicine, Immunology, Oncology +16

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy

Takeshi Masuda, Noboru Hattori, Akinobu Hamada et al. · Cancer Chemotherapy and Pharmacology · 2011 · 97 citations

Medicine, Oncology, Pharmacology +17

XBP1-FoxO1 interaction regulates ER stress-induced autophagy in auditory cells

Akihiro Kishino, Ken Hayashi, Chiaki Hidai et al. · Scientific Reports · 2017 · 79 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14